Phase I - Clinical Trial to Assess Safety of Ultraviolet (UV) Phototherapy for the Prevention of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation
Treatment will be given with a portable, easy to operate device named "EUMATRON". this
device contains a UV- lamp. 250 cc of blood from a peripheric vein is going through the
device into a bottle with Low dose Heparin and returning to patient's body. procedure takes
~20 minutes.
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
safety and tolerability of UV-c phototherapy for the Prevention of Graft versus Host Disease after allogeneic stem cell transplantation
6 months
Reuven Or, MD
Principal Investigator
Bone Marrow transplantation, cancer immunotherapy & immunobiology research center, Hadassah University Hospital, Ein - Kerem, Jerusalem, Israel
Israel: Israeli Health Ministry Pharmaceutical Administration
UV-GVHD - HMO-CTIL
NCT00524953
September 2007
September 2008
Name | Location |
---|